MitoRx Therapeutics (MitoRx), a platform biotechnology company developing novel mitochondrial-targeted sulfide-donor therapeutics (mtH2SD) in obesity-related disorders and myopathies announces the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback